PDS Implant with Ranibizumab clinical trials
PDS Implant with Ranibizumab is named as an intervention in 2 current clinical trials in our USA, UK, Germany, France, Spain, Italy, Belgium, Switzerland, Austria, Turkey, Brazil, Mexico, Taiwan, Australia and Israel registers. 1 is recruiting patients now. All registered phases are Phase 3. The lead sponsor is Hoffmann-La Roche. The most-studied condition is Neovascular Age-Related Macular Degeneration.
Patient leaflets for PDS Implant with Ranibizumab
The package leaflet is the official guide for patients that comes with every medicine. These links go to the regulators that publish it.
- UKUnited Kingdom: Search MHRA ProductsPatient information leaflets and SmPCs for UK-licensed products.
- USUnited States: Search DailyMedFDA-approved labels, including patient and medication guides.
Leaflets differ between brands and countries; always read the one that comes with your own medicine. This is regulatory information, not medical advice.
Trials by status
Trials by phase
Clinical trials of PDS Implant with Ranibizumab
2 trials| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
Extension Study for the Port Delivery System With Ranibizumab (Portal)
NCT03683251 · Neovascular Age-Related Macular Degeneration
|
Phase 3 | Recruiting | Hoffmann-La Roche | UK, USA, Germany, France, Spain, Italy, Belgium, Switzerland, Austria, Turkey, Brazil, Mexico, Taiwan, Australia, Israel |
|
A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME
NCT04108156 · Diabetic Macular Edema
|
Phase 3 | Active, closed | Hoffmann-La Roche | USA |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
Conditions studied with PDS Implant with Ranibizumab
2 conditionsSponsors
lead sponsor per trial| Lead sponsor | Trials |
|---|---|
| Hoffmann-La Roche | 2 |
By country register
A trial with sites in more than one country appears in each of those registers.
Related compounds
Questions about PDS Implant with Ranibizumab trials
How many clinical trials are testing PDS Implant with Ranibizumab?
2 current trials in our USA, UK, Germany, France, Spain, Italy, Belgium, Switzerland, Austria, Turkey, Brazil, Mexico, Taiwan, Australia and Israel registers name PDS Implant with Ranibizumab as a drug or biological intervention, as of the registry sync on 9 November 2026. Completed and withdrawn studies are not counted.
Are PDS Implant with Ranibizumab trials recruiting patients?
Yes. 1 of the 2 trials is recruiting: 1 with sites in USA, 1 with sites in UK, 1 with sites in Germany, 1 with sites in France, 1 with sites in Spain, 1 with sites in Italy, 1 with sites in Belgium, 1 with sites in Switzerland, 1 with sites in Austria, 1 with sites in Turkey, 1 with sites in Brazil, 1 with sites in Mexico, 1 with sites in Taiwan, 1 with sites in Australia and 1 with sites in Israel. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Who sponsors PDS Implant with Ranibizumab clinical trials?
The lead sponsor is Hoffmann-La Roche. The number in brackets is how many trials each organisation leads.
Where does this information come from?
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how PDS Implant with Ranibizumab works or whether it is effective, and it is not medical advice.
How this page is built
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how PDS Implant with Ranibizumab works or whether it is effective. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, intervention names and synonyms, phase, overall status, lead sponsor and conditions for every trial on this page
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists PDS Implant with Ranibizumab (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 9 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.